News coverage about Dentsply Sirona (NASDAQ:XRAY) has trended somewhat positive recently, according to Accern Sentiment. The research firm identifies negative and positive media coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Dentsply Sirona earned a daily sentiment score of 0.12 on Accern’s scale. Accern also gave news headlines about the medical instruments supplier an impact score of 46.3479602120125 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
These are some of the headlines that may have impacted Accern Sentiment’s scoring:
- DENTSPLY SIRONA’s (XRAY) “Hold” Rating Reiterated at Cleveland Research (americanbankingnews.com)
- Q1 2018 EPS Estimates for DENTSPLY SIRONA Inc (XRAY) Reduced by Analyst (americanbankingnews.com)
- Head to Head Comparison: Straumann (SAUHF) & DENTSPLY SIRONA (XRAY) (americanbankingnews.com)
- DENTSPLY SIRONA (XRAY) Upgraded by Barrington Research to “Outperform” (americanbankingnews.com)
Several equities research analysts have recently weighed in on the company. Cleveland Research reissued a “hold” rating on shares of Dentsply Sirona in a research note on Thursday. JPMorgan Chase decreased their price target on Dentsply Sirona from $75.00 to $70.00 and set an “overweight” rating for the company in a research note on Monday, March 5th. Barrington Research reissued an “outperform” rating and issued a $70.00 price target (down previously from $73.00) on shares of Dentsply Sirona in a research note on Monday, March 5th. HC Wainwright set a $63.00 price target on Dentsply Sirona and gave the company a “hold” rating in a research note on Monday, March 5th. Finally, BidaskClub cut Dentsply Sirona from a “sell” rating to a “strong sell” rating in a research note on Wednesday, February 28th. Three equities research analysts have rated the stock with a sell rating, four have given a hold rating and nine have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $67.36.
Dentsply Sirona (NASDAQ:XRAY) last released its earnings results on Thursday, March 1st. The medical instruments supplier reported $0.82 EPS for the quarter, topping the consensus estimate of $0.81 by $0.01. Dentsply Sirona had a positive return on equity of 8.35% and a negative net margin of 39.39%. The business had revenue of $1.09 billion during the quarter, compared to analysts’ expectations of $1.06 billion. During the same quarter last year, the firm posted $0.67 earnings per share. The firm’s revenue was up 9.5% on a year-over-year basis. equities analysts expect that Dentsply Sirona will post 2.74 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 13th. Investors of record on Thursday, March 29th will be paid a dividend of $0.0875 per share. The ex-dividend date is Wednesday, March 28th. This represents a $0.35 annualized dividend and a yield of 0.71%. Dentsply Sirona’s dividend payout ratio is currently 13.16%.
In related news, Director Eric Brandt sold 6,409 shares of the firm’s stock in a transaction that occurred on Monday, January 8th. The stock was sold at an average price of $68.04, for a total transaction of $436,068.36. Following the completion of the sale, the director now owns 12,073 shares of the company’s stock, valued at $821,446.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.99% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This article was first reported by Ticker Report and is owned by of Ticker Report. If you are accessing this article on another site, it was stolen and reposted in violation of US & international copyright & trademark law. The legal version of this article can be viewed at https://www.tickerreport.com/banking-finance/3339360/dentsply-sirona-xray-receiving-somewhat-favorable-news-coverage-study-shows.html.
About Dentsply Sirona
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Receive News & Ratings for Dentsply Sirona Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply Sirona and related companies with MarketBeat.com's FREE daily email newsletter.